nach oben

Erschienen in:

01.05.2015 | Original article

Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients

verfasst von: Dr. J.U. Schmohl, MD, K. Daub, S.N.I. von Ungern-Sternberg, S. Lindemann, T. Schönberger, T. Geisler, M. Gawaz, P. Seizer, MD

Erschienen in: Herz | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Upon coincubation with platelet aggregates, CD34⁺ progenitor cells have the potential to differentiate into foam cells. There is evidence that progenitor cells from diabetic and nondiabetic patients have different properties, which may affect the patients’ prognosis. In this study we investigated an in vitro model of foam cell formation based on patient-derived CD34⁺ progenitor cells. We analyzed the growth characteristics as well as the M-CSF-release and matrix metalloproteinase (MMP) synthesis from CD34⁺ progenitor cell-derived foam cells originating from diabetic and nondiabetic patients.

Methods and results

Bone marrow samples were obtained from 38 patients who were elected for thoracic surgery. CD34⁺ progenitor cells from diabetic and nondiabetic patients were isolated and incubated with platelets from healthy volunteers. Foam cell formation was confirmed by immunostaining (CD68) and quantified by light microscopy. Whereas the absolute number of foam cells was not affected, the negative slope in the growth curve was seen significantly later in the diabetic group. In supernatants derived from“diabetic” CD34⁺ progenitor cells, MMP-9 was significantly enhanced, whereas MMP-2 activity or M-CSF-release was not affected significantly.

Conclusion

In a coculture model of CD34⁺ progenitor cells with platelets, we show for the first time that“diabetic” CD34⁺ progenitor cells exhibit functional differences in their differentiation to foam cells concerning growth characteristics and release of MMP-9.

Eastman RC, Javitt JC, Herman WH et al (1997) Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 20(5):725–734CrossRefPubMed

Barzilay JI, Spiekerman CF, Kuller LH et al (2001) Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 24(7):1233–1239CrossRefPubMed

Segal MS, Shah R, Afzal A et al (2006) Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55(1):102–109CrossRefPubMed

Sagel J, Colwell JA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetus mellitus. Ann Intern Med 82(6):733–738CrossRefPubMed

Calverley DC, Hacker MR, Loda KA et al (2003) Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus. Br J Haematol 121(1):139–142CrossRefPubMed

Cabeza N, Li Z, Schulz C et al (2004) Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53(8):2117–2121CrossRefPubMed

Tepper OM, Galiano RD, Capla JM et al (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106(22):2781–2786CrossRefPubMed

Zhang LJ, Liu WX, Chen YD et al (2010) Proliferation, migration and apoptosis activities of endothelial progenitor cells in acute coronary syndrome. Chin Med J (Engl) 123(19):2655–2661

Fadini GP, Sartore S, Albiero M et al (2006) Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26(9):2140–2146CrossRefPubMed

10.

Hamed S, Brenner B, Abassi Z et al (2010) Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res 126(3):166–174CrossRefPubMed

11.

Gough PJ, Gomez IG, Wille PT, Raines EW (2006) Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116(1):59–69CrossRefPubMedCentralPubMed

12.

Galis ZS, Sukhova GK, Kranzhofer R et al (1995) Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 92(2):402–406CrossRefPubMedCentralPubMed

13.

Daub K, Lindemann S, Langer H et al (2007) The evil in atherosclerosis: adherent platelets induce foam cell formation. Semin Thromb Hemost 33(2):173–178CrossRefPubMed

14.

Ma H, Liu G, Ding W et al (2008) Diabetes-induced alteration of F4/80+ macrophages: a study in mice with streptozotocin-induced diabetes for a long term. J Mol Med (Berl) 86(4):391–400

15.

Hayek T, Hussein K, Aviram M et al (2005) Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose. Atherosclerosis 183(1):25–33CrossRefPubMed

16.

Kunjathoor VV, Wilson DL, LeBoeuf RC (1996) Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97(7):1767–1773CrossRefPubMedCentralPubMed

17.

Gantman A, Fuhrman B, Aviram M, Hayek T (2010) High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx. Biochem Biophys Res Commun 391(1):523–528CrossRefPubMed

18.

Cui X, Kushiyama A, Yoneda M et al (2010) Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy. Diabetes Res Clin Pract 87(1):57–63CrossRefPubMed

19.

Shashkin PN, Jain N, Miller YI et al (2006) Insulin and glucose play a role in foam cell formation and function. Cardiovasc Diabetol 5:13. doi:10.1186/1475-2840-5-13CrossRefPubMedCentralPubMed

20.

Daub K, Langer H, Seizer P et al (2006) Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB J 20(14):2559–2561CrossRefPubMed

21.

Daub K, Siegel-Axel D, Schonberger T et al (2010) Inhibition of foam cell formation using a soluble CD68-Fc fusion protein. J Mol Med (Berl) 88(9):909–920

22.

Schmidt R, Bultmann A, Ungerer M et al (2006) Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation 113(6):834–841CrossRefPubMed

23.

Seizer P, Schonberger T, Schott M et al (2010) EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis 209(1):51–57CrossRefPubMed

24.

Siefert SA, Sarkar R (2012) Matrix metalloproteinases in vascular physiology and disease. Vascular 20(4):210–216CrossRefPubMed

25.

Jiang XB, Wang JS, Liu DH et al (2012) Overexpression of matrix metalloproteinase-9 is correlated with carotid intraplaque hemorrhage in a swine model. J Neurointerv Surg. doi:10.1136/neurintsurg-2012-010401

26.

Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8(11):1227–1234CrossRefPubMed

27.

Stellos K, Bigalke B, Borst O et al (2013) Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of CD34+ cells in the ischaemic microcirculation. Eur Heart J 34(32):2548–2556CrossRefPubMed

28.

Stellos K, Langer H, Daub K et al (2008) Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 117(2):206–215CrossRefPubMed

29.

Massberg S, Konrad I, Schurzinger K et al (2006) Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203(5):1221–1233CrossRefPubMedCentralPubMed

30.

Stellos K, Bigalke B, Langer H et al (2009) Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. Eur Heart J 30(5):584–593CrossRefPubMed

31.

Langer H, May AE, Daub K et al (2006) Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 98(2):e2–e10. doi:10.1161/01.RES. 0000201285.87524.9eCrossRefPubMed

32.

Stellos K, Langer H, Gnerlich S et al (2010) Junctional adhesion molecule A expressed on human CD34+ cells promotes adhesion on vascular wall and differentiation into endothelial progenitor cells. Arterioscler Thromb Vasc Biol 30(6):1127–1136CrossRefPubMed

33.

Stellos K, Panagiota V, Gnerlich S et al (2012) Expression of junctional adhesion molecule-C on the surface of platelets supports adhesion, but not differentiation, of human CD34 cells in vitro. Cell Physiol Biochem 29(1–2):153–162

34.

Stellos K, Seizer P, Bigalke B et al (2010) Platelet aggregates-induced human CD34+ progenitor cell proliferation and differentiation to macrophages and foam cells is mediated by stromal cell derived factor 1 in vitro. Semin Thromb Hemost 36(2):139–145CrossRefPubMed

35.

Seizer P, Schiemann S, Merz T et al (2010) CD36 and macrophage scavenger receptor a modulate foam cell formation via inhibition of lipid-laden platelet phagocytosis. Semin Thromb Hemost 36(2):157–162CrossRefPubMed

36.

Shiau MY, Tsai ST, Tsai KJ et al (2006) Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med 73(7):1024–1028PubMed

37.

Worley JR, Hughes DA, Dozio N et al (2007) Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes. Cardiovasc Diabetol 6:21CrossRefPubMedCentralPubMed

38.

Zhu P, Ren M, Yang C et al (2012) Involvement of RAGE, MAPK and NF-kappaB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 21(2):123–129CrossRefPubMed

39.

Zhang F, Banker G, Liu X et al (2011) The novel function of advanced glycation end products in regulation of MMP-9 production. J Surg Res 171(2):871–876CrossRefPubMedCentralPubMed

40.

Dasu MR, Devaraj S, Zhao L et al (2008) High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57(11):3090–3098CrossRefPubMedCentralPubMed

41.

Shanmugam N, Gaw Gonzalo IT, Natarajan R (2004) Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes 53(3):795–802CrossRefPubMed

42.

Shanmugam N, Reddy MA, Guha M, Natarajan R (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52(5):1256–1264CrossRefPubMed

43.

Guha M, Bai W, Nadler JL, Natarajan R (2000) Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275(23):17728–17739CrossRefPubMed

44.

Hua KF, Wang SH, Dong WC et al (2012) High glucose increases nitric oxide generation in lipopolysaccharide-activated macrophages by enhancing activity of protein kinase C-alpha/delta and NF-kappaB. Inflamm Res 61(10):1107–1116CrossRefPubMed

45.

Cecchetti L, Tolley ND, Michetti N et al (2011) Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood 118(7):1903–1911CrossRefPubMedCentralPubMed

46.

Sheu JR, Fong TH, Liu CM et al (2004) Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol 143(1):193–201CrossRefPubMedCentralPubMed

47.

Kalvegren H, Jonsson S, Jonasson L (2011) Release of matrix metalloproteinases-1 and −2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay. Platelets 22(8):572–578CrossRefPubMed

48.

Catanzaro OL, Dziubecki D, Labal E, Sirois P (2010) Activation of peritoneal macrophages during the evolution of type 1 diabetes (insulitis) in streptozotocin-treated mice. Peptides 31(10):1884–1887CrossRefPubMed

Titel: Differential MMP-9 activity in CD34+progenitor cell-derived foam cells from diabetic and normoglycemic patients
verfasst von: Dr. J.U. Schmohl, MD
K. Daub
S.N.I. von Ungern-Sternberg
S. Lindemann
T. Schönberger
T. Geisler
M. Gawaz
P. Seizer, MD
Publikationsdatum: 01.05.2015
Verlag: Urban & Vogel
Erschienen in: Herz / Ausgabe Sonderheft 3/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-013-4012-y

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods and results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 3/2015

ECG-gated coronary angiography enables submillisievert imaging in invasive cardiology

Left atrial myxoma in a patient with paroxysmal atrial fibrillation

Latest-generation catheterization systems enable invasive submillisievert coronary angiography

Nonbacterial endocarditis presenting as a right ventricular tumor in assumed Behçet’s disease